Full Professor(heuristic)

Genetic Associations and Epidemiology · Genetics

h-index40
i10-index122
Publications294
Citations5,479

Grants

11 total · 7 active

NIH #5R01CA262899-04

Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation

Expiring Soon
Amount
$594K
Period
2021-08-012026-07-31
PIs
3
Est. capacity / PI
~0 students

Awarded at ROSWELL PARK CANCER INSTITUTE CORP

NIH #5R01CA262899-03

Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation

Expiring Soon
Amount
$503K
Period
2021-08-012026-07-31
PIs
3
Est. capacity / PI
~0 students

Awarded at ROSWELL PARK CANCER INSTITUTE CORP

NIH #5R01CA262899-02

Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation

Expiring Soon
Amount
$464K
Period
2021-08-012026-07-31
PIs
3
Est. capacity / PI
~0 students

Awarded at ROSWELL PARK CANCER INSTITUTE CORP

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

All Grants

11 total · 7 active

NIH #5R01CA262899-04

Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation

Expiring Soon
Amount
$594K
Period
2021-08-012026-07-31
PIs
3
Est. capacity / PI
~0 students

Awarded at ROSWELL PARK CANCER INSTITUTE CORP

NIH #5R01CA262899-03

Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation

Expiring Soon
Amount
$503K
Period
2021-08-012026-07-31
PIs
3
Est. capacity / PI
~0 students

Awarded at ROSWELL PARK CANCER INSTITUTE CORP

NIH #5R01CA262899-02

Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation

Expiring Soon
Amount
$464K
Period
2021-08-012026-07-31
PIs
3
Est. capacity / PI
~0 students

Awarded at ROSWELL PARK CANCER INSTITUTE CORP

NIH #1R01CA262899-01

Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation

Expiring Soon
Amount
$954K
Period
2021-08-012026-07-31
PIs
3
Est. capacity / PI
~0 students

Awarded at ROSWELL PARK CANCER INSTITUTE CORP

NIH #4U01CA260731-04

Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor

Active
Amount
$952K
Period
2022-09-012027-08-31
PIs
3
Est. capacity / PI
~1 students

Awarded at UNIVERSITY OF VIRGINIA

NIH #7U01CA260731-02

Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor

Active
Amount
$522K
Period
2022-09-012027-08-31
PIs
3
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF VIRGINIA

NIH #5R01CA262899-05

Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation

Active
Amount
$606K
Period
2021-08-012027-07-31
PIs
3
Est. capacity / PI
~0 students

Awarded at ROSWELL PARK CANCER INSTITUTE CORP

NIH #5U01CA260731-03

Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor

Amount
$484K
Period
2022-09-012025-08-31
PIs
3
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF VIRGINIA

NIH #1U01CA260731-01A1

Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor

Amount
$512K
Period
2022-09-012023-06-26
PIs
3
Est. capacity / PI
~0 students

Awarded at VIRGINIA COMMONWEALTH UNIVERSITY

NIH #5R03CA223730-02

Genetic underpinnings of ethnic disparities in bone toxicities between Hispanic and non-Hispanic children treated for acute lymphoblastic leukemia

Amount
$87K
Period
2017-12-052020-11-30
PIs
3
Est. capacity / PI
~0 students

Awarded at ROSWELL PARK CANCER INSTITUTE CORP

NIH #1R03CA223730-01

Genetic underpinnings of ethnic disparities in bone toxicities between Hispanic and non-Hispanic children treated for acute lymphoblastic leukemia

Amount
$87K
Period
2017-12-052019-11-30
PIs
3
Est. capacity / PI
~0 students

Awarded at ROSWELL PARK CANCER INSTITUTE CORP

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 3 of 3
Open author page on OpenAlex →